Indaptus Therapeutics Valuation

INDP Stock  USD 1.76  0.01  0.57%   
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Indaptus Therapeutics retains a regular Real Value of $3.29 per share. The prevalent price of the firm is $1.76. Our model calculates the value of Indaptus Therapeutics from evaluating the firm fundamentals such as Return On Equity of -0.98, return on asset of -0.58, and Shares Owned By Insiders of 30.85 % as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Indaptus Therapeutics' valuation include:
Price Book
2.5451
Enterprise Value
11.5 M
Enterprise Value Ebitda
1.0264
Undervalued
Today
1.76
Please note that Indaptus Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Indaptus Therapeutics is based on 3 months time horizon. Increasing Indaptus Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Indaptus Therapeutics' intrinsic value may or may not be the same as its current market price of 1.76, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.76 Real  3.29 Target  8.0 Hype  1.76 Naive  1.83
The intrinsic value of Indaptus Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Indaptus Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
3.29
Real Value
3.29
Upside
Estimating the potential upside or downside of Indaptus Therapeutics helps investors to forecast how Indaptus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Indaptus Therapeutics more accurately as focusing exclusively on Indaptus Therapeutics' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.6-0.6-0.6
Details
Hype
Prediction
LowEstimatedHigh
1.761.761.76
Details
Naive
Forecast
LowNext ValueHigh
1.831.831.83
Details
2 Analysts
Consensus
LowTarget PriceHigh
7.288.008.88
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Indaptus Therapeutics' intrinsic value based on its ongoing forecasts of Indaptus Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Indaptus Therapeutics' closest peers.

Indaptus Therapeutics Investments

23.37 Million

Indaptus Valuation Trend

Knowing Indaptus Therapeutics' actual value is paramount for traders to make sound investment determinations. Indaptus Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Indaptus Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Indaptus Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Indaptus Market Cap

Indaptus Therapeutics is currently regarded as number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 1.08 Trillion. Indaptus Therapeutics adds roughly 21.09 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Workforce  Total debt  Revenue  Valuation

Indaptus Therapeutics Total Value Analysis

Indaptus Therapeutics is currently forecasted to have valuation of 11.5 M with market capitalization of 21.09 M, debt of 175.05 K, and cash on hands of 33.01 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Indaptus Therapeutics fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
11.5 M21.09 M175.05 K33.01 M

Indaptus Therapeutics Asset Utilization

One of the ways to look at asset utilization of Indaptus is to check how much profit was generated for every dollar of assets it reports. Indaptus Therapeutics retains a negative application of resources of -0.58 (percent), losing $0.005817 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Indaptus Therapeutics shows how discouraging it operates for each dollar spent on its resources.

Indaptus Therapeutics Ownership Allocation

Indaptus Therapeutics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.

Indaptus Therapeutics Profitability Analysis

Net Loss for the year was (15.42 M) with profit before overhead, payroll, taxes, and interest of 0.

About Indaptus Therapeutics Valuation

The stock valuation mechanism determines the current worth of Indaptus Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Indaptus Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Indaptus Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Indaptus Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Indaptus Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Indaptus Therapeutics. We calculate exposure to Indaptus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Indaptus Therapeutics's related companies.
Last ReportedProjected for Next Year
Gross Profit-1.3 K-1.3 K

8 Steps to conduct Indaptus Therapeutics' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Indaptus Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Indaptus Therapeutics' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Indaptus Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Indaptus Therapeutics' revenue streams: Identify Indaptus Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Indaptus Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Indaptus Therapeutics' growth potential: Evaluate Indaptus Therapeutics' management, business model, and growth potential.
  • Determine Indaptus Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Indaptus Therapeutics' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Indaptus Therapeutics Growth Indicators

Investing in growth stocks can be very risky. If the company such as Indaptus Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding8.4 M

Indaptus Therapeutics Current Valuation Indicators

Valuation refers to the process of determining the present value of Indaptus Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Indaptus we look at many different elements of the entity such as Indaptus's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Indaptus Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Indaptus Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Indaptus Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Indaptus Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Indaptus Therapeutics' worth.

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.